Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial

被引：124
|
作者：
Haibel, H [1 ]
Rudwaleit, M
Brandt, HC
Grozdanovic, Z
Listing, J
Kupper, H
Braun, J
Sieper, J
机构：
[1] Klinikum Benjamin Franklin, D-12200 Berlin, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Abbott GmbH & Co, Ludwigshafen, Germany
[4] Ctr Rheumatol Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词：
D O I：
10.1002/art.21563
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：678 / 681
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Preliminary results of an open-label, 20-week trial.
    Haibel, H
    Brandt, HC
    Rudwaleit, M
    Listing, J
    Braun, J
    Kupper, H
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S217 - S217
  • [22] Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis.
    Baraliakos, Xenofon
    Braun, Jurgen
    Laurent, D. D.
    Baeten, D.
    van der Heijde, D.
    Sieper, J.
    Emery, Paul
    McInnes, Iain B.
    van Laar, J.
    Landewe, R.
    Wordsworth, Paul
    Wollenhaupt, Jurgen
    Kellner, Herbert
    Wright, Andrew
    Vandenhende, Francois
    Radford, Kath
    Borah, Babul
    Wolfgang, Hueber
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S250 - S251
  • [23] Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical data supported by magnetic resonance imaging
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [24] Magnetic resonance imaging (MRI) of the anterior and posterior spinal segments during adalimumab (Humira®) therapy for active ankylosing spondylites (AS)
    Rudwaleit, M.
    Haibel, H.
    Althoft, C.
    Zeise, E.
    Kupper, H.
    Sieper, J.
    Hermann, K. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 724 - 724
  • [25] USTEKINUMAB EFFECTIVELY REDUCES ACTIVE INFLAMMATION AS DETECTED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A 28-WEEK, PROSPECTIVE, OPEN-LABEL, PROOF-OF-CONCEPT STUDY (TOPAS)
    Poddubnyy, D.
    Hermann, K. G.
    Callhoff, J.
    Listing, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 833 - 833
  • [26] USTEKINUMAB EFFECTIVELY REDUCES ACTIVE INFLAMMATION AS DETECTED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A 28-WEEK, PROSPECTIVE, OPEN-LABEL, PROOF-OF-CONCEPT STUDY (TOPAS)
    Poddubnyy, D.
    Hermann, K. -G.
    Callhoff, J.
    Listing, J.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 120 - 120
  • [27] SPINAL MOBILITY IN THE CERVICAL AND THE LUMBAR SPINE CORRELATES WITH MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH ANKYLOSING SPONDYLITIS - MORE RESULTS FROM THE GO-RAISE TRIAL
    Baraliakos, X.
    Hermann, K. -G.
    Xu, S.
    Hsu, B.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 730 - 730
  • [28] Ixekizumab significantly improves signs, symptoms and spinal inflammation of active ankylosing spondylitis/radiographic axial spondyloarthritis: 16-week results of a phase 3 randomised, active and placebo-controlled trial
    Compan, Navarro, V
    Redlich, K.
    Bird, P.
    Bello, N.
    Pum, G.
    Leage, Liu S.
    Nassab, M. H.
    SWISS MEDICAL WEEKLY, 2019, : 16S - 17S
  • [29] Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial
    van der Heijde, Desiree
    Wei, James Cheng-Chung
    Dougados, Maxime
    Mease, Philip J.
    Deodhar, Atul A.
    Maksymowych, Walter P.
    van den Bosch, Filip
    Sieper, Joachim
    Tomita, Tetsuya
    Landewe, Robert B. M.
    Mallbris, Lotus
    Zhao, Fangyi
    Adams, David
    Pangallo, Beth
    Carlier, Hilde
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] IXEKIZUMAB SIGNIFICANTLY IMPROVES SIGNS, SYMPTOMS AND SPINAL INFLAMMATION OF ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 16-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL
    Navarro Compan, Victoria
    Redlich, Kurt
    Bird, Paul
    Bello, Natalia
    Nassab, Mani Haschemi
    Pum, Georg
    Leage, Soyi Liu
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 12 - 13
12345